Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2026-05-19 Capital/Financing Update
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a press release announcing the issuance of “Interest Shares” to satisfy semi‐annual interest on secured debentures and providing an update on insider bridge financing activities. This relates to fundraising/financing activities and capital structure changes rather than a full report or regulatory filing. Hence, it falls under a Capital/Financing Update.
2026-05-19 English
News release - English.pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) of shareholders for Tudor Gold Corp. It details the date, location, agenda items including receiving audited financial statements, election of directors, appointment of auditors, and approval of stock option plans. It also provides instructions for voting by proxy and accessing meeting materials electronically. The document does not contain the actual financial statements or detailed reports but rather serves as an announcement and invitation to the AGM. The length is under 5,000 characters and it references where the meeting materials can be accessed, consistent with a notice rather than the full report or presentation. Therefore, the document fits the category of AGM Information (AGM-R).
2026-04-17 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing PharmaCielo's intention to issue common shares as interest payments on secured debentures. It discusses the terms of the share issuance, regulatory approvals required, and forward-looking statements. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is focused on a financing activity related to capital structure changes (issuing shares to satisfy interest payments). It is not an annual or interim report, audit report, or earnings release. The content fits the definition of a Capital/Financing Update (CAP) as it provides an update on the company's financing activities and capital structure changes.
2026-04-17 English
News release - English.pdf
Regulatory Filings
2026-03-17 English
Notice of meeting - English.pdf
Regulatory Filings
2026-03-06 English
News release - English.pdf
Regulatory Filings
2026-03-02 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.